Medpace Holdings Inc (MEDP) — Capital Reinvestment Ratio

Latest as of June 2026: 0.15x

Medpace Holdings Inc (MEDP) has a Capital Reinvestment Ratio of 0.15x as of June 2026, meaning it reinvests 0% of its operating cash flow ($162.01 Million) in capital expenditures ($23.91 Million). Check MEDP tangible net assets ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.15x
Capex / Operating Cash Flow

Operating Cash Flow

$162.01 Million
USD

Capital Expenditures

$23.91 Million
USD

Data as of

Jun 2026
Most recent filing

Medpace Holdings Inc Capital Reinvestment Ratio (2013–2025)

This chart tracks Medpace Holdings Inc's Capital Reinvestment Ratio across 13 annual periods. For the full cash flow conversion analysis, see how efficiently does Medpace Holdings Inc generate cash.

Annual Capital Reinvestment Ratio for Medpace Holdings Inc (2013–2025)

Year-by-year Capital Reinvestment Ratio for Medpace Holdings Inc from 2013 to 2025. See Medpace Holdings Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2025 0.04x $713.22 Million $31.36 Million ▼ -26.8%
2024 0.06x $608.82 Million $36.55 Million ▼ -29.0%
2023 0.08x $433.37 Million $36.65 Million ▼ -11.0%
2022 0.10x $388.05 Million $36.88 Million ▼ -11.5%
2021 0.11x $263.33 Million $28.27 Million ▼ -11.4%
2020 0.12x $258.68 Million $31.34 Million ▲ +36.5%
2019 0.09x $201.87 Million $17.91 Million ▼ -13.3%
2018 0.10x $156.58 Million $16.02 Million ▼ -18.9%
2017 0.13x $97.39 Million $12.29 Million ▼ -14.5%
2016 0.15x $91.73 Million $13.54 Million ▲ +96.0%
2015 0.08x $85.87 Million $6.46 Million ▲ +6.5%
2014 0.07x $75.20 Million $5.32 Million ▲ +52.1%
2013 0.05x $98.14 Million $4.56 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow